ArrowMark Colorado Holdings LLC 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 1:29 pm Sale | 2020-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | ArrowMark Colorado Holdings LLC | 1,156,338 3.700% | -118,086 (-9.27%) | Filing |
| 2020-04-10 4:11 pm Sale | 2020-03-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | ArrowMark Colorado Holdings LLC | 1,274,424 6.300% | -1,009,237 (-44.19%) | Filing |